Data from various retinal clinical trials suggest that there is a difference in efficacy in anti-VEGF therapies for patients with lower vision, according to a speaker here. During a presentation at ...

The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was well tolerated.

Early detection and monitoring are key to the diagnosis and management of ocular diseases, including glaucoma, retinal and ...

The collaboration will focus on preventive solutions, workshops, and public awareness. King Faisal Specialist Hospital and ...

This code is designed for detecting Diabetic Retinopathy in retinal fundus images using a deep learning approach. It preprocesses the images, applies data augmentation to improve model generalization, ...

Retinal Biologics Industry. The retinal biologics market experienced significant growth in 2021, with total revenue reaching ...

Ozempic and Wegovy have become popular options for people looking to lose weight, but there are some risks and side effects ...

Diabetic retinopathy is a common complication in people with type 1 and type 2 diabetes, progressing from mild, moderate, and ...

AbbVie (NYSE: ABBV) and REGENXBIO Inc. (Nasdaq: RGNX) today announced updates to the ABBV-RGX-314 clinical program.

Diabetes affects millions worldwide, and while most know about its impact on blood sugar and organ health, vision loss ...

Valo Health’s Rho kinase (ROCK) 1 and 2 inhibitor has failed to reduce the severity of diabetic retinopathy in a phase 2 trial, leading the Flagship-founded biotech to drop the candidate.

Global diabetic retinopathy market is anticipated to exhibit a CAGR of 6.43% during the forecast period 2024-2031 due to increasing prevalence of diabetes globally and rising demand for advanced ...